Gan Lee Pharmaceuticals Begins First-In-Human Trial in U.S. ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING and BRIDGEWATER, N.J., Mar 10, 2022, /PRNewswire-AsiaNet/-- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, single, ascendin...
Authors: LATEST ASIANET NEWS RELEASES